Possis Medical Inc - Current report filing (8-K)
March 25 2008 - 12:50PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15 (d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported):
|
March
24, 2008
|
|
POSSIS
MEDICAL, INC.
|
(Exact
name of registrant as specified in its charter)
|
Minnesota
|
0-944
|
41-0783184
|
(State
or other jurisdiction
of
incorporation)
|
(Commission
File Number)
|
(IRS
Employer Identification No.)
|
9055
Evergreen Boulevard NW, Minneapolis, MN
|
55433-8003
|
(Address
of principal executive offices)
|
(Zip
Code)
|
Registrant's
telephone number, including area code
|
763-780-4555
|
Not
Applicable
|
(Former
name or former address, if changed since last report.)
|
Check the
appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any
of the following provisions:
⃞
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
⃞
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
⃞
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
⃞
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Item
7.01 Regulation FD Disclosure
On March 24, 2008, Possis Medical, Inc., announced that the United
States Court of Appeals for the Eighth Circuit has affirmed the Federal
District Court's dismissal of a shareholder lawsuit that was filed June
5, 2005. The suit had alleged that Possis Medical violated federal
securities laws by misrepresenting material information about the
Company’s AngioJet® Rheolytic™ Thrombectomy System prior to the August
2004 public disclosure of the results of the Company’s AiMI clinical
trial. A copy of the press release is furnished as Exhibit 99.1 to this
Report.
Item
9.01 Financial Statements and Exhibits
[c]
|
Exhibits
|
|
|
99.1
|
Press Release, dated March 24, 2008, issued by Possis Medical, Inc.
|
SIGNATURES
Pursuant to
the requirements of the Securities Exchange Act of 1934, the registrant
has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Possis
Medical, Inc.
|
|
(Registrant)
|
|
|
|
Date:
|
March
24, 2008
|
|
|
|
|
By:
|
/s/
Jules L. Fisher
|
|
|
Jules
L. Fisher
|
|
|
Vice
President, Finance and Chief Financial Officer
|
|
EXHIBIT
INDEX
Exhibit No.
|
Description
|
|
|
99.1
|
Press Release, dated March 24, 2008, issued by Possis Medical, Inc.
|
Possis Medical (MM) (NASDAQ:POSS)
Historical Stock Chart
From May 2024 to Jun 2024
Possis Medical (MM) (NASDAQ:POSS)
Historical Stock Chart
From Jun 2023 to Jun 2024